Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.78p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.05
  • 52 Week Low: 0.75
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 221,809
  • Market Cap: £3.31m
  • RiskGrade: 304

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
34.30% above the market average34.30% above the market average34.30% above the market average34.30% above the market average34.30% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average
Price Book Ratio
56.45% above the market average56.45% above the market average56.45% above the market average56.45% above the market average56.45% above the market average
75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average75.51% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
84.69% below the market average84.69% below the market average84.69% below the market average84.69% below the market average84.69% below the market average
43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average43.86% below the sector average
Price Chg 3m
94.9% below the market average94.9% below the market average94.9% below the market average94.9% below the market average94.9% below the market average
75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
67.13% below the market average67.13% below the market average67.13% below the market average67.13% below the market average67.13% below the market average
69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average69.81% below the sector average
Momentum 20
16.24% below the market average16.24% below the market average16.24% below the market average16.24% below the market average16.24% below the market average
1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average1.89% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
91.3% below the market average91.3% below the market average91.3% below the market average91.3% below the market average91.3% below the market average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
56.66% below the market average56.66% below the market average56.66% below the market average56.66% below the market average56.66% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.74% below the market average87.74% below the market average87.74% below the market average87.74% below the market average87.74% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average
Operating Profit Loss
70.06% below the market average70.06% below the market average70.06% below the market average70.06% below the market average70.06% below the market average
18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
49.79% below the market average49.79% below the market average49.79% below the market average49.79% below the market average49.79% below the market average
26.92% below the sector average26.92% below the sector average26.92% below the sector average26.92% below the sector average26.92% below the sector average
Cash
21.06% below the market average21.06% below the market average21.06% below the market average21.06% below the market average21.06% below the market average
3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average3.7% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
23.92% below the market average23.92% below the market average23.92% below the market average23.92% below the market average23.92% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 0.78p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.05
52 Week Low 0.75
Volume 221,809
Shares Issued 427.35m
Market Cap £3.31m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.11% above the market average22.11% above the market average22.11% above the market average22.11% above the market average22.11% above the market average
84.91% above the sector average84.91% above the sector average84.91% above the sector average84.91% above the sector average84.91% above the sector average
Price Trend
93.47% below the market average93.47% below the market average93.47% below the market average93.47% below the market average93.47% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for 18-Apr-2024

Time Volume / Share Price
17:07 110,000 @ 0.78p
10:27 110,000 @ 0.78p
08:21 1,809 @ 0.75p

Evgen Pharma Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page